111 related articles for article (PubMed ID: 1794374)
1. In vitro susceptibility of tetracycline-resistant strains of Ureaplasma urealyticum to newer macrolides and quinolones, and a streptogramin.
Renaudin H; Bébéar C; Robertson JA
Eur J Clin Microbiol Infect Dis; 1991 Nov; 10(11):984-6. PubMed ID: 1794374
[No Abstract] [Full Text] [Related]
2. Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibilities to reference macrolides, tetracyclines, and quinolones.
Kenny GE; Cartwright FD
Antimicrob Agents Chemother; 2001 Sep; 45(9):2604-8. PubMed ID: 11502536
[TBL] [Abstract][Full Text] [Related]
3. In-vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum to clinafloxacin, PD 131628, ciprofloxacin and comparator drugs.
Cohen MA; Huband MD
J Antimicrob Chemother; 1997 Aug; 40(2):308-9. PubMed ID: 9302005
[No Abstract] [Full Text] [Related]
4. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum.
Renaudin H; Bébéar C
Eur J Clin Microbiol Infect Dis; 1990 Nov; 9(11):838-41. PubMed ID: 1964899
[TBL] [Abstract][Full Text] [Related]
5. [In vitro sensitivity to antibiotics of genital mycoplasmas isolated in Toulouse. Study of new molecules (macrolides and quinolones)].
Bauriaud R; Séror C; Lareng MB; Lefèvre JC
Pathol Biol (Paris); 1992 May; 40(5):479-82. PubMed ID: 1495830
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones.
Waites KB; Cassell GH; Canupp KC; Fernandes PB
Antimicrob Agents Chemother; 1988 Oct; 32(10):1500-2. PubMed ID: 2973283
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic and genetic characteristics of macrolide and lincosamide resistant Ureaplasma urealyticum isolated in Guangzhou, China.
Lu C; Ye Tl; Zhu Gx; Feng Py; Ma H; Lu Rb; Lai W
Curr Microbiol; 2010 Jul; 61(1):44-9. PubMed ID: 20043167
[TBL] [Abstract][Full Text] [Related]
8. Occurrence and antimicrobial susceptibility of Ureaplasma parvum (Ureaplasma urealyticum biovar 1) and Ureaplasma urealyticum (Ureaplasma urealyticum biovar 2) from patients with adverse pregnancy outcomes and normal pregnant women.
Martínez MA; Ovalle A; Santa-Cruz A; Barrera B; Vidal R; Aguirre R
Scand J Infect Dis; 2001; 33(8):604-10. PubMed ID: 11525356
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and antibiotic susceptibility of Mycoplasma hominis and Ureaplasma urealyticum in genital samples collected over 6 years at a Serbian university hospital.
Skiljevic D; Mirkov D; Vukicevic J
Indian J Dermatol Venereol Leprol; 2016; 82(1):37-41. PubMed ID: 26728808
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of sparfloxacin and other antimicrobial agents against genital pathogens.
Lefèvre JC; Bauriaud R; Gaubert E; Escaffre MC; Lareng MB
Chemotherapy; 1992; 38(5):303-7. PubMed ID: 1337506
[TBL] [Abstract][Full Text] [Related]
11. Isolation and chemoantibiotic resistance of Ureaplasma urealyticum in HIV-1 infected patients.
Martinelli F; Caruso A; Ausenda S; Corulli M; Licenziati S; Garrafa E; Turano A
New Microbiol; 1998 Jul; 21(3):233-40. PubMed ID: 9699202
[TBL] [Abstract][Full Text] [Related]
12. [Voice on the treatment of ureaplasmas infections].
Biernat-Sudolska M; Rojek-Zakrzewska D; Drzewiecki A
Przegl Epidemiol; 2009; 63(1):85-8. PubMed ID: 19522233
[TBL] [Abstract][Full Text] [Related]
13. In vitro antimicrobial profile of Ureaplasma urealyticum from genital tract of childbearing-aged women in Northern and Southern Italy.
Pignanelli S; Pulcrano G; Iula VD; Zaccherini P; Testa A; Catania MR
APMIS; 2014 Jun; 122(6):552-5. PubMed ID: 24106832
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial activity of Manuka honey against antibiotic-resistant strains of the cell wall-free bacteria Ureaplasma parvum and Ureaplasma urealyticum.
Hillitt KL; Jenkins RE; Spiller OB; Beeton ML
Lett Appl Microbiol; 2017 Mar; 64(3):198-202. PubMed ID: 27992658
[TBL] [Abstract][Full Text] [Related]
15. [Antimicrobial susceptibility of Ureaplasma urealyticum and ureaplasma parvum isolated from premature infants with respiratory disorders].
Biernat-Sudolska M; Rojek-Zakrzewska D; Drzewiecki A; Lauterbach R
Przegl Epidemiol; 2007; 61(2):371-6. PubMed ID: 17956056
[TBL] [Abstract][Full Text] [Related]
16. Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma spp.
Duffy LB; Crabb D; Searcey K; Kempf MC
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():29-33. PubMed ID: 10824029
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and antibiotic susceptibility of Ureaplasma urealyticum in Malaysian neonates with respiratory distress.
Tay ST; Boo NY; Khoo TB; Koay AS; Rohani MY
Med J Malaysia; 1997 Dec; 52(4):409-11. PubMed ID: 10968119
[TBL] [Abstract][Full Text] [Related]
18. Comparative in-vitro activity of levofloxacin, other fluoroquinolones, doxycycline and erythromycin against Ureaplasma urealyticum and Mycoplasma hominis.
Ullmann U; Schubert S; Krausse R
J Antimicrob Chemother; 1999 Jun; 43 Suppl C():33-6. PubMed ID: 10404335
[TBL] [Abstract][Full Text] [Related]
19. Assessment of antibiotic susceptibility of Ureaplasma urealyticum from prostitutes and outpatient clinic patients using the E-test and agar dilution method.
Cakan H; Polat E; Kocazeybek B; Ocal P; Cepni I; Aslan M; Salihoğlu F; Altaş K
Chemotherapy; 2003 May; 49(1-2):39-43. PubMed ID: 12714809
[TBL] [Abstract][Full Text] [Related]
20. In vitro susceptibility of Ureaplasma urealyticum clinical isolates to new macrolides.
Kanamoto Y; Miyake Y; Suginaka H; Usui T
Chemotherapy; 1991; 37(4):256-9. PubMed ID: 1790724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
